Status: current, Defined. Date: 31-Mar 2011. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3020311000168112 | Naglazyme 5 mg/5 mL injection, 5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3020321000168117 | Naglazyme (galsulfase 5 mg / 5 mL) injection, 1 x 5 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Naglazyme 5 mg/5 mL injection, 5 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Naglazyme 5 mg/5 mL injection, 5 mL vial | Is a | galsulfase 5 mg/5 mL injection, 5 mL vial | true | Inferred relationship | Some | ||
| Naglazyme 5 mg/5 mL injection, 5 mL vial | has TPUU | Naglazyme 5 mg/5 mL injection, 5 mL vial | true | Inferred relationship | Some | 1 | |
| Naglazyme 5 mg/5 mL injection, 5 mL vial | has TP | Naglazyme | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Naglazyme 5 mg/5 mL injection, 5 mL vial | Is a | True | Naglazyme 5 mg/5 mL injection, 5 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR